Low frequency of enterohemorrhagic, enteroinvasive and diffusely adherent Escherichia coli in children under 5 years in rural Mozambique: a case-control study.


Journal

BMC infectious diseases
ISSN: 1471-2334
Titre abrégé: BMC Infect Dis
Pays: England
ID NLM: 100968551

Informations de publication

Date de publication:
07 Sep 2020
Historique:
received: 23 03 2020
accepted: 28 08 2020
entrez: 7 9 2020
pubmed: 8 9 2020
medline: 22 9 2020
Statut: epublish

Résumé

Diarrheagenic Escherichia coli (DEC) are among the leading pathogens associated with endemic diarrhea in low income countries. Yet, few epidemiological studies have focused the contribution of enterohemorrhagic E. coli (EHEC), enteroinvasive E. coli (EIEC) and diffusely adherent E. coli (DAEC). We assessed the contribution of EHEC, EIEC and DAEC isolated from stool samples from a case-control study conducted in children aged < 5 years in Southern Mozambique between December 2007 and November 2012. The isolates were screened by conventional PCR targeting stx1 and stx2 (EHEC), ial and ipaH (EIEC), and daaE (DAEC) genes. We analyzed 297 samples from cases with less-severe diarrhea (LSD) matched to 297 controls, and 89 samples from cases with moderate-to-severe diarrhea (MSD) matched to 222 controls, collected between November 3, 2011 and November 2, 2012. DEC were more common among LSD cases (2.7%, [8/297] of cases vs. 1.3% [4/297] of controls; p = 0.243]) than in MSD cases (0%, [0/89] of cases vs. 0.4%, [1/222] of controls; p = 1.000). Detailed analysis revealed low frequency of EHEC, DAEC or EIEC and no association with diarrhea in all age strata. Although the low frequency, EIEC was predominant in LSD cases aged 24-59 months (4.1% for cases vs. 0% for controls), followed by DAEC in similar frequency for cases and controls in infants (1.9%) and lastly EHEC from one control. Analysis of a subset of samples from previous period (December 10, 2007 and October 31, 2011) showed high frequency of DEC in controls compared to MSD cases (16.2%, [25/154] vs. 11.9%, [14/118], p = 0.383, respectively). Among these, DAEC predominated, being detected in 7.7% of cases vs. 17.6% of controls aged 24-59 months, followed by EIEC in 7.7% of cases vs. 5.9% of controls for the same age category, although no association was observed. EHEC was detected in one sample from cases and two from controls. Our data suggests that although EHEC, DAEC and EIEC are less frequent in endemic diarrhea in rural Mozambique, attention should be given to their transmission dynamics (e.g. the role on sporadic or epidemic diarrhea) considering that the role of asymptomatic individuals as source of dissemination remains unknown.

Sections du résumé

BACKGROUND BACKGROUND
Diarrheagenic Escherichia coli (DEC) are among the leading pathogens associated with endemic diarrhea in low income countries. Yet, few epidemiological studies have focused the contribution of enterohemorrhagic E. coli (EHEC), enteroinvasive E. coli (EIEC) and diffusely adherent E. coli (DAEC).
METHODS METHODS
We assessed the contribution of EHEC, EIEC and DAEC isolated from stool samples from a case-control study conducted in children aged < 5 years in Southern Mozambique between December 2007 and November 2012. The isolates were screened by conventional PCR targeting stx1 and stx2 (EHEC), ial and ipaH (EIEC), and daaE (DAEC) genes.
RESULTS RESULTS
We analyzed 297 samples from cases with less-severe diarrhea (LSD) matched to 297 controls, and 89 samples from cases with moderate-to-severe diarrhea (MSD) matched to 222 controls, collected between November 3, 2011 and November 2, 2012. DEC were more common among LSD cases (2.7%, [8/297] of cases vs. 1.3% [4/297] of controls; p = 0.243]) than in MSD cases (0%, [0/89] of cases vs. 0.4%, [1/222] of controls; p = 1.000). Detailed analysis revealed low frequency of EHEC, DAEC or EIEC and no association with diarrhea in all age strata. Although the low frequency, EIEC was predominant in LSD cases aged 24-59 months (4.1% for cases vs. 0% for controls), followed by DAEC in similar frequency for cases and controls in infants (1.9%) and lastly EHEC from one control. Analysis of a subset of samples from previous period (December 10, 2007 and October 31, 2011) showed high frequency of DEC in controls compared to MSD cases (16.2%, [25/154] vs. 11.9%, [14/118], p = 0.383, respectively). Among these, DAEC predominated, being detected in 7.7% of cases vs. 17.6% of controls aged 24-59 months, followed by EIEC in 7.7% of cases vs. 5.9% of controls for the same age category, although no association was observed. EHEC was detected in one sample from cases and two from controls.
CONCLUSIONS CONCLUSIONS
Our data suggests that although EHEC, DAEC and EIEC are less frequent in endemic diarrhea in rural Mozambique, attention should be given to their transmission dynamics (e.g. the role on sporadic or epidemic diarrhea) considering that the role of asymptomatic individuals as source of dissemination remains unknown.

Identifiants

pubmed: 32894092
doi: 10.1186/s12879-020-05380-1
pii: 10.1186/s12879-020-05380-1
pmc: PMC7475947
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

659

Subventions

Organisme : Bill and Melinda Gates Foundation
ID : OPP1033572

Références

FEMS Immunol Med Microbiol. 2005 Jan 1;43(1):67-72
pubmed: 15607638
Clin Infect Dis. 2012 Dec;55 Suppl 4:S232-45
pubmed: 23169936
Mol Microbiol. 1989 Dec;3(12):1729-34
pubmed: 2695745
Western Pac Surveill Response J. 2019 Apr 29;10(2):14-21
pubmed: 31720050
Clin Microbiol Rev. 1998 Jan;11(1):142-201
pubmed: 9457432
Epidemiol Infect. 2014 Dec;142(12):2559-66
pubmed: 24534429
Clin Infect Dis. 2012 Dec;55 Suppl 4:S294-302
pubmed: 23169941
J Clin Microbiol. 2000 Jan;38(1):7-12
pubmed: 10618054
BMC Pediatr. 2013 Mar 19;13:36
pubmed: 23506294
Indian J Med Microbiol. 2015 Oct-Dec;33(4):528-32
pubmed: 26470959
J Infect Dev Ctries. 2015 Jul 04;9(6):661-4
pubmed: 26142678
BMC Microbiol. 2013 Feb 01;13:22
pubmed: 23374248
J Infect Dev Ctries. 2013 Mar 14;7(3):214-9
pubmed: 23492999
Infect Immun. 1985 May;48(2):378-83
pubmed: 2859247
J Clin Microbiol. 2010 Jan;48(1):302-6
pubmed: 19864474
Clin Microbiol Infect. 2007 May;13(5):516-24
pubmed: 17331124
PLoS Negl Trop Dis. 2015 Mar 04;9(3):e0003510
pubmed: 25738580
Clin Microbiol Rev. 2013 Oct;26(4):822-80
pubmed: 24092857
Nat Rev Microbiol. 2004 Feb;2(2):123-40
pubmed: 15040260
Lancet. 2013 Jul 20;382(9888):209-22
pubmed: 23680352
Lancet. 2017 Dec 17;388(10063):3027-3035
pubmed: 27839855
Clin Infect Dis. 2017 Oct 1;65(7):1144-1151
pubmed: 28575304
FEMS Microbiol Lett. 2009 Aug;297(2):137-49
pubmed: 19527295
Diagn Microbiol Infect Dis. 2010 Oct;68(2):117-22
pubmed: 20846583
Am J Trop Med Hyg. 2007 Mar;76(3):522-7
pubmed: 17360878
Lancet Glob Health. 2019 May;7(5):e568-e584
pubmed: 31000128
PLoS One. 2015 May 14;10(5):e0119824
pubmed: 25973880
Infect Immun. 1984 Aug;45(2):534-6
pubmed: 6146569
J Clin Microbiol. 2005 Oct;43(10):5362-5
pubmed: 16208019
BMC Infect Dis. 2015 Nov 20;15:539
pubmed: 26589805
J Med Microbiol. 2008 Mar;57(Pt 3):359-363
pubmed: 18287300
J Infect Dis. 2019 Jun 19;220(2):213-218
pubmed: 30816414
Int J Epidemiol. 2013 Oct;42(5):1309-18
pubmed: 24159076
BMC Infect Dis. 2013 Sep 08;13:418
pubmed: 24010735
J Clin Microbiol. 2008 Jan;46(1):352-4
pubmed: 17989192

Auteurs

Marcelino Garrine (M)

Centro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique.
Global Health and Tropical Medicine (GHTM), Instituto de Higiene e Medicina Tropical (IHMT), Universidade Nova de Lisboa (UNL), Lisbon, Portugal.

Glória Matambisso (G)

Centro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique.

Nélio Nobela (N)

Centro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique.

Delfino Vubil (D)

Centro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique.

Sérgio Massora (S)

Centro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique.

Sozinho Acácio (S)

Centro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique.
Instituto Nacional de Saúde (INS), Ministério da Saúde, Maputo, Mozambique.

Tacilta Nhampossa (T)

Centro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique.
Instituto Nacional de Saúde (INS), Ministério da Saúde, Maputo, Mozambique.

Pedro Alonso (P)

Centro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique.
ISGlobal, Hospital Clínic-Universitat de Barcelona, Barcelona, Spain.

Inácio Mandomando (I)

Centro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique. inacio.mandomando@manhica.net.
Instituto Nacional de Saúde (INS), Ministério da Saúde, Maputo, Mozambique. inacio.mandomando@manhica.net.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH